Key facts
- Quantinuum priced its IPO at $60 per share.
- The company raised $1.68 billion in its upsized initial public offering.
- Quantinuum will sell 28 million shares of Class A common stock.
- The quantum computing company will trade on the Nasdaq under the ticker "QNT".
- Honeywell will retain about 48.1% of the company's combined voting power post-offering.
Quantinuum Inc., a quantum computing company formed in 2021 through the merger of Honeywell's quantum computing business and Cambridge Quantum, has announced the pricing of its upsized initial public offering. The company will sell 28,000,000 shares of its Class A common stock at a public price of $60.00 per share, resulting in gross proceeds of approximately $1.68 billion before deducting underwriting discounts and commissions. Quantinuum has also granted the underwriters a 30-day option to purchase additional shares. The company is expected to begin trading on the Nasdaq under the ticker symbol "QNT" on Thursday. This IPO represents a significant event for the emerging quantum computing sector, testing investor appetite for companies in this rapidly advancing but high-cost field. Honeywell will retain about 48.1% of the company's combined voting power after the offering is completed. Analysts expect Quantinuum's IPO to have an outsized impact on the quantum computing sector, given the limited number of publicly traded companies in the space. Breakthroughs in quantum computing have spurred bets that these machines could eventually outperform conventional computers on certain complex tasks. Sentiment was also buoyed after the U.S. government announced a $2 billion initiative to take equity stakes in nine quantum computing companies, including a planned $100 million investment in Quantinuum. Shares of peer IonQ have surged about 52% this year, giving the company a market value of about $25.47 billion. Quantinuum develops quantum hardware and software systems designed to solve complex computational problems, benefiting from Honeywell's backing and expanding into software, cybersecurity, and quantum networking applications. Commercial adoption remains limited, but investors are primarily buying into the long-term opportunity. Japan's RIKEN research institute accounted for roughly 60% of the company's 2025 revenue, highlighting the industry's continued reliance on government and research spending. Investors should monitor whether the company broadens its customer base and increases the number and value of commercial contracts over time, as the industry grapples with high development costs, technological complexity, and an uncertain timeline for widespread commercial adoption. J.P. Morgan and Morgan Stanley are the lead active book-running managers for the offering.